Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
111,111,111
-
Number of holders
-
265
-
Total 13F shares, excl. options
-
73,023,087
-
Shares change
-
+4,108,713
-
Total reported value, excl. options
-
$8,126,468,764
-
Value change
-
+$543,592,499
-
Put/Call ratio
-
97.43%
-
Number of buys
-
129
-
Number of sells
-
-138
-
Price
-
$111.31
Significant Holders of NovoCure Ltd - Common Stock (NVCR) as of Q3 2020
348 filings reported holding NVCR - NovoCure Ltd - Common Stock as of Q3 2020.
NovoCure Ltd - Common Stock (NVCR) has 265 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73,023,087 shares
of 111,111,111 outstanding shares and own 65.72% of the company stock.
Largest 10 shareholders include FMR LLC (9,956,360 shares), VANGUARD GROUP INC (8,207,262 shares), Capital International Investors (8,198,569 shares), BAILLIE GIFFORD & CO (8,124,645 shares), Capital World Investors (6,630,017 shares), BlackRock Inc. (5,976,306 shares), CREDIT SUISSE AG/ (1,646,970 shares), MACQUARIE GROUP LTD (1,514,755 shares), Darsana Capital Partners LP (1,325,000 shares), and MORGAN STANLEY (1,322,587 shares).
This table shows the top 265 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.